Some additional info was provided as follows:
1/4th of the shares subject to the option vests one year following the date of grant; thereafter, 1/48th of the shares subject to the option vests monthly over the next three years.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Ambit Biosciences Corp makes a similar move, sign up!